GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 74 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $593,000 | -46.3% | 123,272 | -32.4% | 0.02% | -40.7% |
| Q3 2019 | $1,105,000 | -31.4% | 182,387 | -26.5% | 0.03% | -22.9% |
| Q2 2019 | $1,610,000 | -32.2% | 248,099 | -26.0% | 0.04% | -32.7% |
| Q1 2019 | $2,376,000 | +489.6% | 335,106 | +304.1% | 0.05% | +420.0% |
| Q4 2018 | $403,000 | -71.3% | 82,926 | -30.4% | 0.01% | -76.7% |
| Q3 2016 | $1,405,000 | +26.5% | 119,066 | +10.8% | 0.04% | +43.3% |
| Q2 2013 | $1,111,000 | – | 107,453 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,500,000 | $25,725,000 | 3.13% |
| CADIAN CAPITAL MANAGEMENT, LP | 3,830,399 | $28,153,000 | 1.28% |
| Mesirow Financial Investment Management, Inc. | 33,001 | $243,000 | 1.25% |
| Bellevue Group AG | 1,339,502 | $9,845,000 | 0.62% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 260,000 | $1,912,000 | 0.58% |
| Lyon Street Capital, LLC | 109,850 | $807,000 | 0.50% |
| Private Wealth Partners, LLC | 300,000 | $2,205,000 | 0.34% |
| Penn Capital Management Company, LLC | 455,064 | $3,345,000 | 0.25% |
| HighTower Advisors, LLC | 2,337,132 | $17,179,000 | 0.12% |
| Schonfeld Strategic Advisors LLC | 376,000 | $2,763,000 | 0.12% |